How accurate is <sup>68</sup>Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (<sup>68</sup>Ga-PSMA PET/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node- based analyses.


Erdem S., Simsek D., Degirmenci E., Aydin R., Bagbudar S., Ozluk Y., ...More

Urologic oncology, vol.40, no.1, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 40 Issue: 1
  • Publication Date: 2022
  • Doi Number: 10.1016/j.urolonc.2021.07.006
  • Journal Name: Urologic oncology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
  • Keywords: Intermediate-high risk prostate cancer, Radical prostatectomy, Lymph node staging, (68)Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (Ga-68-PSMA PET/CT), PSMA, DISSECTION, EXPRESSION, DIAGNOSIS, CT
  • Istanbul University Affiliated: Yes

Abstract

Background and aim: Gallium-68 (68Ga)-Prostate Membrane Specific Antigen Positron Emission Tomography/Computed Tomography (68Ga-PSMA PET/CT) is an emerging diagnostic modality which is gaining importance in individualized prostate cancer (PCa) management era. This study aimed to investigate the diagnostic accuracy of Ga-68-PSMA PET/CT on primary LN staging before radical prostatectomy (RP) in intermediate and high risk PCa.